Myostatin as a plausible biomarker for early stage of sarcopenic obesity
Chisaki Ishibashi, Kaori Nakanishi, Makoto Nishida, Haruki Shinomiya, Maki Shinzawa, Daisuke Kanayama, Ryohei Yamamoto, Takashi Kudo, Izumi Nagatomo, Keiko Yamauchi-Takihara · 2024
Read Myostatin as a plausible biomarker for early stage of sarcopenic obesity by Chisaki Ishibashi, Kaori Nakanishi, Makoto Nishida, Haruki Shinomiya, Maki Shinzawa, Daisuke Kanayama, Ryohei Yamamoto, Takashi Kudo, Izumi Nagatomo, Keiko Yamauchi-Takihara (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11577097.txt.
Description
Chisaki Ishibashi and a team of co-authors study early sarcopenic obesity in middle aged women in a 2024 paper. This state pairs low muscle mass with high body fat and harms health, yet its rate in healthy women was not well known. The team measure body makeup in hundreds of university staff at health checks and test a blood protein as a marker.
About six percent of the women met their criteria for the state. That group had weaker grip, worse blood fats, and more insulin resistance than healthy peers. Their blood levels of the muscle protein myostatin were lower, against first intuition. The authors propose myostatin as a plausible early marker.
Catalog record
| CREATOR | Chisaki Ishibashi, Kaori Nakanishi, Makoto Nishida, Haruki Shinomiya, Maki Shinzawa, Daisuke Kanayama, Ryohei Yamamoto, Takashi Kudo, Izumi Nagatomo, Keiko Yamauchi-Takihara |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |